Key verticals adopting hemophilia treatment include: - Pfizer Inc, Novo Nordisk A/S, Hoffmann-La Roche Ltd, Bayer AG, Shire, CSL Behring, Grifols, S.A, Biogen Inc, Sanofi S.A, Octapharma AG, Novartis AG, Sangamo Therapeutics, Inc.